Jin Dai

Mr. Jin Dai


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2012 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
MNMasahiro Nakajima
Masahiro Nakajima
DSDongquan Shi
Dongquan Shi
JDJin Dai
Jin Dai
ATAspasia Tsezou
Aspasia Tsezou
MZMinghao Zheng
Minghao Zheng
QJQing Jiang
Qing Jiang
Osteoarthritis (OA) is a common disease with a genetic component for its etiology. Recently, a genetic association of a single nucleotide polymorphism (SNP), rs17039192 in HIF‐2α with knee OA has been reported in a Japanese population; however, controversy exits for its replication and a role of HIF‐2α in OA. This study aimed to evaluate the association of the SNP by a large‐scale replication study. A total of 8,457 subjects (3,129 OA cases and 5,328 controls) from seven independent cohorts from six countries (Japan, China, Taiwan, Korea, Greece, and Australia) were recruited and genotyped. The association of rs17039192 with knee OA was evaluated by meta‐analyses. The association of the HIF‐2α SNP was not replicated in any of the populations. Contrary to the previous report, the odds ratios (ORs) of the risk allele frequency were all less than 1. A combined analysis for the seven populations also showed no replication of the association (OR = 0.91, 95% confidence interval = 0.81–1.03). Our large‐scale meta‐analysis showed that the association of rs17039192 in HIF‐2α with knee OA is negative. The significance of HIF‐2α in human OA (idiopathic OA as a common disease) should be further evaluated carefully. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 30:1244–1248, 2012

3 October 2023 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
JDJin Dai
Jin Dai
WDWen Dai
Wen Dai
WLWen-Qing Li
Wen-Qing Li

28 January 2023 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
TXTong Xia
Tong Xia
GGGilbert c Gee
Gilbert c Gee
Jian LiJian Li
Jian Li
XLXinyue Liu
Xinyue Liu
JDJin Dai
Jin Dai
LCLiwei Chen
Liwei Chen
OBJECTIVES: During the coronavirus disease 2019 (COVID-19) pandemic, a growing prevalence of racial and ethnic discrimination occurred when many Americans struggled to maintain healthy lifestyles. This study investigated the associations of racial and ethnic discrimination with changes in exercise and screen time during the pandemic in the United States.METHODS: We included 2,613 adults who self-identified as non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, or Hispanic from the Health, Ethnicity, and Pandemic study, a cross-sectional survey conducted among a nationally representative sample of United States adults between October and November 2020. We assessed self-reported racial and ethnic discrimination by measuring COVID-19-related racial and ethnic bias and examined its associations with changes in exercise and screen time using multivariable logistic regression models. We analyzed data between September 2021 and March 2022.RESULTS: COVID-19-related racial and ethnic bias was associated with decreased exercise time among non-Hispanic Asian (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.13 to 1.89) and Hispanic people (OR, 1.91; 95% CI, 1.32 to 2.77), and with increased screen time among non-Hispanic Black people (OR, 1.94; 95% CI, 1.33 to 2.85), adjusting for age, sex, education, marital status, annual household income, insurance, and employment status.CONCLUSIONS: Racial and ethnic discrimination may have adversely influenced exercise and screen time changes among racial and ethnic minorities during the COVID-19 pandemic in the United States. Further studies are needed to investigate the mechanisms through which racial and ethnic discrimination can impact lifestyles and to develop potential strategies to address racial and ethnic discrimination as a barrier to healthy lifestyles.

6 February 2025 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
JDJin Dai
Jin Dai
WDWen Dai
Wen Dai
WLWen-Qing Li
Wen-Qing Li
Aims: The aim of this study was to evaluate associations of muscle-strengthening activity (MSA) with all-cause, cardiovascular disease (CVD), and cancer mortality in adults with diabetes, independent of and jointly with moderate-to-vigorous aerobic physical activity (MVPA). Methods and results: This prospective cohort study included 29 609 adults with diabetes free of CVD and cancer from the US National Health Interview Survey 1997–2018 (baseline). Muscle-strengthening activity and MVPA were derived from standardized questionnaires. Mortality by 2019 was ascertained through linkage to the National Death Index. Cox models were utilized to estimate adjusted hazard ratios (aHRs). Over 270 178 person-years, 6716 all-cause, 1995 CVD, and 1202 cancer deaths were documented in the study population (mean age, 55.7 years, 51.6% female). There were U-shaped associations of MSA with all-cause mortality risk, with ≤ 3 times/week associated with mortality benefits. Compared with no MSA, aHRs of all-cause mortality were 0.72 (95% confidence interval, 0.47–1.10) for MSA < 1 time/week, 0.58 (0.44–0.77) for 1 time/week, 0.76 (0.61–0.96) for 2 times/week, 0.80 (0.67–0.96) for 3 times/week, 0.97 (0.65–1.47) for 4–6 times/week, and 0.99 (0.83–1.19) for ≥ 7 times/week. Non-linear associations with CVD and cancer mortality were also observed. These associations did not vary by age or sex. Jointly, compared with no MSA and MVPA < 150 min/week, adults performing MSA ≤ 2 times/week and MVPA ≥ 150 min/week had the lowest all-cause and CVD mortality risk. Conclusion: For adults with diabetes, performing MSA ≤ 3 times/week may be associated with lower all-cause, CVD, and cancer mortality risk, independent of MVPA. Jointly performing MSA ≤ 2 times/week and MVPA ≥ 150 min/week may confer the lowest all-cause and CVD mortality risk.

8 October 2024 in Diabetes Care
Verified
Journal Article
Closed access
JDJin Dai
Jin Dai
RNRoch Nianogo
Roch Nianogo
TMTannaz Moin
Tannaz Moin
NWNathan D. Wong
Nathan D. Wong
QQQibin Qi
Qibin Qi
LCLiwei Chen
Liwei Chen
OBJECTIVE: To examine the associations of energy intake and glycemic load (GL) in different time periods during the day with cardiovascular disease (CVD) mortality risk in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: This cohort study included 2,911 adults with diabetes from who were part of the U.S. National Health and Nutrition Examination Survey 2003–2014 (baseline), and CVD mortality data obtained by linkage to the National Death Index through 2019. Energy intake and GL in early morning (6:00–7:59 a.m.), late morning (8:00–10:59 a.m.), afternoon (11:00 a.m.–5:59 p.m.), evening (6:00–11:59 p.m.), and night (0:00–5:59 a.m.) were derived from two 24-h dietary recalls at baseline. Cox models were used to estimate hazard ratios (HRs) for CVD mortality, adjusted for total energy intake, diet quality, sociodemographic and lifestyle characteristics, and medical conditions. RESULTS: At baseline, the study population (51.8% female, 62.3% non-Hispanic White) had a mean age of 57.4 (SE, 0.4) years. Over a median follow-up of 9.3 (interquartile range = 6.8, 12.1) years, 190 CVD deaths were documented. Energy intake and GL in late morning were inversely associated with CVD mortality risk (per 100-kcal energy intake increment, HR 0.90 [95% CI 0.83–0.98]; per 10-unit GL increment, HR 0.86 [95% CI 0.77–0.95]). In contrast, energy intake and GL at night were positively associated with CVD mortality risk (per 100-kcal energy intake increment, HR 1.22 [95% CI 1.07–1.40]; per 10-unit GL increment, HR 1.44 [95% CI 1.17–1.77]). CONCLUSIONS: For adults with type 2 diabetes, late morning may be a protective eating time against CVD mortality, whereas night may be a detrimental eating time.

8 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LCLiwei Chen
Liwei Chen
JDJin Dai
Jin Dai
GYGuoqi Yu
Guoqi Yu
WPWei Wei Pang
Wei Wei Pang
MRMohammad Rahman
Mohammad Rahman
Cuilin ZhangCuilin Zhang
Cuilin Zhang
Objective: the aim of this study was to identify plasma metabolomic markers of Dietary Approaches to Stop Hypertension (DASH) dietary patterns in pregnant women. Methods: This study included 186 women who had both dietary intake and metabolome measured from a nested case-control study within the NICHD Fetal Growth Studies–Singletons cohort (FGS). Dietary intakes were ascertained at 8–13 gestational weeks (GW) using the Food Frequency Questionnaire (FFQ) and DASH scores were calculated based on eight food and nutrient components. Fasting plasma samples were collected at 15–26 GW and untargeted metabolomic profiling was performed. Multivariable linear regression models were used to examine the association of individual metabolites with the DASH score. Least absolute shrinkage and selection operator (LASSO) regression was used to select a panel of metabolites jointly associated with the DASH score. Results: Of the total 460 known metabolites, 92 were individually associated with DASH score in linear regressions, 25 were selected as a panel by LASSO regressions, and 18 were identified by both methods. Among the top 18 metabolites, there were 11 lipids and lipid-like molecules (i.e., TG (49:1), TG (52:2), PC (31:0), PC (35:3), PC (36:4) C, PC (36:5) B, PC (38:4) B, PC (42:6), SM (d32:0), gamma-tocopherol, and dodecanoic acid), 5 organic acids and derivatives (i.e., asparagine, beta-alanine, glycine, taurine, and hydroxycarbamate), 1 organic oxygen compound (i.e., xylitol), and 1 organoheterocyclic compound (i.e., maleimide). Conclusions: our study identified plasma metabolomic markers for DASH dietary patterns in pregnant women, with most of being lipids and lipid-like molecules.